We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
3251
Praxis Precision Medicines
PRAX
$10.3B
$267K ﹤0.01%
7,836
QTUM icon
3252
Defiance Quantum ETF
QTUM
$5.82B
$267K ﹤0.01%
7,394
+90
+1% +$3.75K
SYM icon
3253
Symbotic
SYM
$5.43B
$267K ﹤0.01%
+23,180
New +$341K
EWG icon
3254
iShares MSCI Germany ETF
EWG
$1.67B
$266K ﹤0.01%
13,458
-70
-0.5% -$1.56K
NDMO icon
3255
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$608M
$266K ﹤0.01%
25,836
+10,377
+67% +$119K
AXSM icon
3256
Axsome Therapeutics
AXSM
$11.2B
$264K ﹤0.01%
5,921
+15
+0.3% +$750
FBRT
3257
Franklin BSP Realty Trust
FBRT
$675M
$264K ﹤0.01%
24,511
+33
+0.1% +$454
MGPI icon
3258
MGP Ingredients
MGPI
$389M
$264K ﹤0.01%
+2,488
New +$267K
TRIP icon
3259
TripAdvisor
TRIP
$1.29B
$264K ﹤0.01%
11,950
-3,496
-23% -$78.3K
MITK icon
3260
Mitek Systems
MITK
$853M
$263K ﹤0.01%
28,717
+15,000
+109% +$151K
RSPS icon
3261
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$248M
$263K ﹤0.01%
+8,550
New +$287K
IMO icon
3262
Imperial Oil
IMO
$64B
$262K ﹤0.01%
6,053
-216
-3% -$9.86K
OPI
3263
DELISTED
Office Properties Income Trust
OPI
$262K ﹤0.01%
18,647
-1,980
-10% -$37.2K
AMRC icon
3264
Ameresco
AMRC
$1.47B
$261K ﹤0.01%
3,927
-1,905
-33% -$117K
NPFD icon
3265
Nuveen Variable Rate Preferred & Income Fund
NPFD
$454M
$261K ﹤0.01%
+14,960
New +$284K
TBBK icon
3266
The Bancorp
TBBK
$2.82B
$261K ﹤0.01%
11,879
+203
+2% +$4.7K
VFL
3267
DELISTED
abrdn National Municipal Income Fund
VFL
$261K ﹤0.01%
23,925
-584
-2% -$6.99K
AAN
3268
DELISTED
The Aaron's Company Inc
AAN
$260K ﹤0.01%
26,755
+2,513
+10% +$33.5K
SCPL
3269
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$260K ﹤0.01%
+22,118
New +$276K
DMAY icon
3270
FT Vest US Equity Deep Buffer ETF May
DMAY
$381M
$259K ﹤0.01%
8,600
+100
+1% +$3.16K
DOL icon
3271
WisdomTree True Developed International Fund
DOL
$848M
$259K ﹤0.01%
6,932
-37
-0.5% -$1.53K
GLU
3272
Gabelli Utility & Income Trust
GLU
$116M
$259K ﹤0.01%
18,550
-862
-4% -$13.8K
KOP icon
3273
Koppers
KOP
$874M
$259K ﹤0.01%
12,470
+423
+4% +$9.74K
PTCT icon
3274
PTC Therapeutics
PTCT
$6.01B
$259K ﹤0.01%
5,169
+13
+0.3% +$637
VMEO
3275
DELISTED
Vimeo
VMEO
$259K ﹤0.01%
64,656
+398
+0.6% +$2.35K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.